Health · Medical Research · 7 hrs ago
Investigational tracer detects early cardiac amyloidosis in phase III study
A phase III study called REVEAL tested an investigational tracer for cardiac amyloidosis.
The study took place in Phoenix.
The tracer binds to amyloid and was assessed for its ability to detect and measure the disease in the heart.
It performed particularly well in cases with low disease burden.
This matters because the study focused on detecting cardiac amyloidosis at an early stage.
The study findings concern an investigational tracer; no next steps are described.
An investigational pan-amyloid binding tracer detected and quantified cardiac amyloidosis in a phase III study.
The tracer performed particularly well in cases with early, low amyloid burden.
The findings came from the REVEAL study.
- Who
- Researchers studied an investigational pan-amyloid binding tracer in the REVEAL study.
- What
- The phase III study assessed the tracer’s ability to detect and quantify cardiac amyloidosis.
- When
- The article was published on October 12, 2026; the study timing is not stated.
- Where
- Phoenix, according to the article’s dateline.
- Why
- To detect and quantify cardiac amyloidosis, particularly in early, low-burden cases.
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Study
- REVEAL
- Phase
- III
- Tracer
- Investigational pan-amyloid binding radiotracer
- Focus
- Early, low-burden cardiac amyloidosis
Sources
Related news
Pope Leo to have surgery to remove an early-detected lung nodule
Woman gives birth after ovarian tissue frozen for more than 20 years
Higher Weight at Dementia Diagnosis Linked to Lower Risk of Death
Four-week study tracks nighttime movement in dogs and their owners
Nearly One-Third of Older Adults With Cognitive Disorders Still Take Risky Drugs
Pregnancy diet linked to lower odds of babies having both colic and eczema
Yoga before bariatric surgery linked to lower noradrenaline levels
Gut Inflammation Reactivated Dormant Breast Cancer Cells in a Mouse Model
Pope Leo XIV to have surgery to remove early-stage lung nodule
Gut lining may remain vulnerable after IBD symptoms improve
Researchers Seek Consensus on Sauna Health Benefits
